The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
Open accessAbstract
Soluble cytokine receptors are frequently found in human serum, most of them possessing antagonistic properties. The Interleukin 6 receptor (IL-6R) is found as a transmembrane protein on hepatocytes and subsets of leukocytes, but soluble isoforms of the IL-6R (sIL-6R) are generated by alternative splicing or by limited proteolysis of the ADisintegrin And Metalloproteinases (ADAM) gene family members ADAM10 and ADAM17. Importantly, the sIL-6R in complex with its ligand Interleukin 6 (IL-6) has agonistic functions and requires cells expressing the signal transducing ß-receptor gp130 but not the membrane-bound IL-6R. We have called this process IL-6 trans-signaling. Naturally occurring isoforms of soluble gp130 (sgp130), which are generated by alternative splicing, are natural inhibitors of IL-6 trans-signaling, leaving IL-6 classic signaling via the membrane-bound IL-6R unaffected. We used recombinant sgp130Fc protein and recently generated transgenic mice expressing high levels of sgp130Fc to discriminate between classic and trans-signaling in vivo, and demonstrated that IL-6 trans-signaling is critically involved in generation and maintenance of several inflammatory and autoimmune diseases including chronic inflammatory bowel disease, rheumatoid arthritis, peritonitis and asthma, as well as inflammation-induced colon cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Self-citationIL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
An Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., et al. (1997) · Nature · doi:10.1038/385733a0 · Cited by 1,378
Regulated Intramembrane Proteolysis
Brown, M. S., Ye, J., Rawson, R. B., & Goldstein, J. L. (2000) · Cell · doi:10.1016/s0092-8674(00)80675-3 · Cited by 1,329
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationInterleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
EDWARDS, D., HANDSLEY, M., & PENNINGTON, C. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.001 · Cited by 1,161
Waterfall Sequence for Intrinsic Blood Clotting
Davie, E. W., & Ratnoff, O. D. (1964) · Science · doi:10.1126/science.145.3638.1310 · Cited by 1,113
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
ADAMs: key components in EGFR signalling and development
Blobel, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1548 · Cited by 1,090
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946
A circadian clock in macrophages controls inflammatory immune responses
Keller, M., Mazuch, J., Abraham, U., Eom, G. D., Herzog, E. D., Volk, H.-D., Kramer, A., & Maier, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906361106 · Cited by 843
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Self-citationMuraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K., & Kishimoto, T. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.332 · Cited by 783
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779
Soluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
Self-citationTGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Self-citationGao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666
Rose-John, S., Scheller, J., Elson, G., & Jones, S. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105674 · Cited by 647
Self-citationSoluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Self-citationThe soluble interleukin 6 receptor: mechanisms of production and implications in disease
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 623
Nicola, N. A., Metcalf, D., Matsumoto, M., & Johnson, G. R. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32158-6 · Cited by 555
Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation
Haass, C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600061 · Cited by 550
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
Inda, M.-D.-M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D. W. Y., Vandenberg, S., Brennan, C., Johns, T. G., Bachoo, R., Hadwiger, P., et al. (2010) · Genes & Development · doi:10.1101/gad.1890510 · Cited by 543
Choy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526
The soluble interleukin‐6 receptor is generated by shedding
Mülberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 506
Self-citationADAMs: focus on the protease domain
Black, R. A., & White, J. M. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80042-2 · Cited by 467
Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies
Lakatos, P. L., & Lakatos, L. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3937 · Cited by 442
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes & Development · doi:10.1101/gad.1549407 · Cited by 422
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.
Ishibashi, T., Kimura, H., Uchida, T., Kariyone, S., Friese, P., & Burstein, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5953 · Cited by 407
Interleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406
Matthews, V., Schuster, B., Schütze, S., Bussmeyer, I., Ludwig, A., Hundhausen, C., Sadowski, T., Saftig, P., Hartmann, D., Kallen, K.-J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210584200 · Cited by 390
Self-citationYao, Z., Fenoglio, S., Gao, D. C., Camiolo, M., Stiles, B., Lindsted, T., Schlederer, M., Johns, C., Altorki, N., Mittal, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009472107 · Cited by 389
Zhou, B.-B. S., Peyton, M., He, B., Liu, C., Girard, L., Caudler, E., Lo, Y., Baribaud, F., Mikami, I., Reguart, N., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.024 · Cited by 374
The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
Jorissen, E., Prox, J., Bernreuther, C., Weber, S., Schwanbeck, R., Serneels, L., Snellinx, A., Craessaerts, K., Thathiah, A., Tesseur, I., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5221-09.2010 · Cited by 363
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
Rose-John, S., Waetzig, G. H., Scheller, J., Grötzinger, J., & Seegert, D. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.613 · Cited by 360
Self-citationIL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.
Okada, M., Kitahara, M., Kishimoto, S., Matsuda, T., Hirano, T., & Kishimoto, T. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.5.1543 · Cited by 359
Intracellular maturation and localization of the tumour necrosis factor α convertase (TACE)
Schlöndorff, J. S., Becherer, J. D., & Blobel, C. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470131 · Cited by 359
Ludwig, A., Hundhausen, C., Lambert, M., Broadway, N., Andrews, R., Bickett, D., Leesnitzer, M., & Becherer, J. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207053258488 · Cited by 356
Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.1120 · Cited by 343
Human soluble IL-6 receptor: its detection and enhanced release by HIV infection
Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suzuki, H., Saito, T., Osugi, Y., Tokunaga, T., & Kishimoto, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2175 · Cited by 331
Chalaris, A., Rabe, B., Paliga, K., Lange, H., Laskay, T., Fielding, C. A., Jones, S. A., Rose-John, S., & Scheller, J. (2007) · Blood · doi:10.1182/blood-2007-01-067918 · Cited by 329
Self-citationEmbryonic lethality in mice homozygous for a processing-deficient allele of Notch1
Huppert, S. S., Le, A., Schroeter, E. H., Mumm, J. S., Saxena, M. T., Milner, L. A., & Kopan, R. (2000) · Nature · doi:10.1038/35016111 · Cited by 323
Maintenance of Pluripotency in Human Embryonic Stem Cells Is STAT3 Independent
Humphrey, R. K., Beattie, G. M., Lopez, A. D., Bucay, N., King, C. C., Firpo, M. T., Rose‐John, S., & Hayek, A. (2004) · STEM CELLS · doi:10.1634/stemcells.22-4-522 · Cited by 319
Self-citationIsolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Horiuchi, K., Kimura, T., Miyamoto, T., Takaishi, H., Okada, Y., Toyama, Y., & Blobel, C. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2686 · Cited by 301
Interleukin-6 and its receptor: from bench to bedside
Scheller, J., & Rose-John, S. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0019-9 · Cited by 292
Self-citationMcLoughlin, R. M., Witowski, J., Robson, R. L., Wilkinson, T. S., Hurst, S. M., Williams, A. S., Williams, J. D., Rose-John, S., Jones, S. A., & Topley, N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17129 · Cited by 281
Self-citationCleavage and Shedding of E-cadherin after Induction of Apoptosis
Steinhusen, U., Weiske, J., Badock, V., Tauber, R., Bommert, K., & Huber, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006102200 · Cited by 278
Interleukin-6 and Soluble Interleukin-6 Receptor: Direct Stimulation of gp130 and Hematopoiesis
Peters, M., Müller, A. M., & Rose-John, S. (1998) · Blood · doi:10.1182/blood.v92.10.3495 · Cited by 276
Self-citationThe soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.
Müllberg, J., Oberthür, W., Lottspeich, F., Mehl, E., Dittrich, E., Graeve, L., Heinrich, P. C., & Rose-John, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.4958 · Cited by 269
Self-citationChalaris, A., Adam, N., Sina, C., Rosenstiel, P., Lehmann-Koch, J., Schirmacher, P., Hartmann, D., Cichy, J., Gavrilova, O., Schreiber, S., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092366 · Cited by 269
Self-citationNowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Self-citationXu, P., & Derynck, R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.034 · Cited by 257
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., Jones, S. A., Rose-John, S., & Scheller, J. (2008) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 245
Self-citationChen, Q., Fisher, D. T., Clancy, K. A., Gauguet, J.-M. M., Wang, W.-C., Unger, E., Rose-John, S., von Andrian, U. H., Baumann, H., & Evans, S. S. (2006) · Nature Immunology · doi:10.1038/ni1406 · Cited by 233
Self-citationOkuda, Y. (1998) · International Immunology · doi:10.1093/intimm/10.5.703 · Cited by 229
Dominitzki, S., Fantini, M. C., Neufert, C., Nikolaev, A., Galle, P. R., Scheller, J., Monteleone, G., Rose-John, S., Neurath, M. F., & Becker, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2041 · Cited by 227
Self-citationNowell, M. A., Williams, A. S., Carty, S. A., Scheller, J., Hayes, A. J., Jones, G. W., Richards, P. J., Slinn, S., Ernst, M., Jenkins, B. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.613 · Cited by 215
Self-citationMatsumoto, S., Hara, T., Mitsuyama, K., Yamamoto, M., Tsuruta, O., Sata, M., Scheller, J., Rose-John, S., Kado, S.-I., & Takada, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0801217 · Cited by 211
Self-citationHoriuchi, S., Koyanagiu, Y., Zhouu, Y., Miyamotou, H., Tanakau, Y., Waki, M., Matsumoto, A., Yamamotou, M., & Yamamotof, N. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240837 · Cited by 197
C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding
Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., & Fuller, G. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.599 · Cited by 196
Jones, G. W., McLoughlin, R. M., Hammond, V. J., Parker, C. R., Williams, J. D., Malhotra, R., Scheller, J., Williams, A. S., Rose-John, S., Topley, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901528 · Cited by 189
Self-citationThe Interleukin-6 Cytokine System Regulates Epidermal Permeability Barrier Homeostasis
Wang, X.-P., Schunck, M., Kallen, K., Neumann, C., Trautwein, C., Rose‐John, S., & Proksch, E. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22736.x · Cited by 188
Self-citationKlouche, M., Bhakdi, S., Hemmes, M., & Rose-John, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4583 · Cited by 178
Self-citationPeters, M., Schirmacher, P., Goldschmitt, J., Odenthal, M., Peschel, C., Fattori, E., Ciliberto, G., Dienes, H.-P., Büschenfelde, K.-H. M. Z., & Rose-John, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.755 · Cited by 170
Self-citationThiol isomerases negatively regulate the cellular shedding activity of ADAM17
Willems, S. H., Tape, C. J., Stanley, P. L., Taylor, N. A., Mills, I. G., Neal, D. E., McCafferty, J., & Murphy, G. (2010) · Biochemical Journal · doi:10.1042/bj20100179 · Cited by 165
Yoshizaki, K., Nishimoto, N., Mihara, M., & Kishimoto, T. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00832010 · Cited by 164
Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses
Müller-Newen, G., Küster, A., Hemmann, U., Keul, R., Horsten, U., Martens, A., Graeve, L., Wijdenes, J., & Heinrich, P. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6347 · Cited by 162
Robak, T., Gladalska, A., Stepień, H., & Robak, E. (1998) · Mediators of Inflammation · doi:10.1080/09629359890875 · Cited by 161
ADAM-17 Expression in Breast Cancer Correlates with Variables of Tumor Progression
McGowan, P. M., Ryan, B. M., Hill, A. D. K., McDermott, E. W. M., O’Higgins, N. J., & Duffy, M. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2092 · Cited by 142
Neural activities of IL‐6‐type cytokines often depend on soluble cytokine receptors
März, P., Otten, U., & Rose‐John, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00755.x · Cited by 127
Self-citationSTAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice
Mitsuyama, K., Matsumoto, S., Rose-John, S., Suzuki, A., Hara, T., Tomiyasu, N., Handa, K., Tsuruta, O., Funabashi, H., Scheller, J., et al. (2006) · Gut · doi:10.1136/gut.2005.079343 · Cited by 123
Self-citationStokes, A., Joutsa, J., Ala‐aho, R., Pitchers, M., Pennington, C. J., Martin, C., Premachandra, D. J., Okada, Y., Peltonen, J. T. K., Grenman, R. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2525 · Cited by 117
Sleep enhances IL‐6 trans‐signaling in humans
Dimitrov, S., Lange, T., Benedict, C., Nowell, M. A., Jones, S. A., Scheller, J., Rose‐John, S., Born, J., Dimitrov, S., Lange, T., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5754fje · Cited by 115
Self-citationWalker, F., Zhang, H., Matthews, V. B., Weinstock, J., Nice, E. C., Ernst, M., Rose‐John, S., & Burgess, A. W. (2007) · Blood · doi:10.1182/blood-2007-10-119636 · Cited by 104
Self-citationRegulation of the proteolytic disintegrin metalloproteinases, the ‘Sheddases’
Murphy, G. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.09.004 · Cited by 103
Colonic Mucosal Interleukin-6 in Inflammatory Bowel Disease
Mitsuyama, K., Sasaki, E., Toyonaga, A., Ikeda, H., Tsuruta, O., Irie, A., Arima, N., Oriishi, T., Harada, K., Fujisaki, K., et al. (2009) · Digestion · doi:10.1159/000200747 · Cited by 103
Oberg, H., Wesch, D., Grüssel, S., Rose‐John, S., & Kabelitz, D. (2006) · International Immunology · doi:10.1093/intimm/dxh396 · Cited by 103
Self-citationPore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide.
Walev, I., Vollmer, P., Palmer, M., Bhakdi, S., & Rose‐John, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7882 · Cited by 102
Self-citationRose‐John, S., & Neurath, M. F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00003-2 · Cited by 100
Self-citationVollmer, P., Walev, I., Rose‐John, S., & Bhakdi, S. (1996) · Infection and Immunity · doi:10.1128/iai.64.9.3646-3651.1996 · Cited by 98
Self-citationKaran, D., Lin, F. C., Bryan, M., Ringel, J. O. R., Moniaux, N., Lin, M., & Batra, S. K. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.5.1365 · Cited by 97
Soluble Human Interleukin‐6 Receptor: Expression in Insect Cells, Purification and Characterization
Weiergräber, O. H., Hemmann, U., Küster, A., Müller‐Newen, G., Schneider, J., Rose‐John, S., Kurschat, P., Brakenhoff, J. P. J., Hart, M. H. L., Stabel, S., et al. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.661_b.x · Cited by 96
Self-citationNuclear translocation of beta-catenin in hereditary and carcinogen- induced intestinal adenomas
Sheng, H., Shao, J., Williams, C. S., Pereira, M. A., Taketo, M. M., Oshima, M., Reynolds, A. B., Washington, M. K., DuBois, R. N., & Beauchamp, R. D. (1998) · Carcinogenesis · doi:10.1093/carcin/19.4.543 · Cited by 96
Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by α- and γ-secretases
Schulte, A., Schulz, B., Andrzejewski, M. G., Hundhausen, C., Mletzko, S., Achilles, J., Reiss, K., Paliga, K., Weber, C., John, S. R., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.100 · Cited by 92
Bank, U., Reinhold, D., Schneemilch, C. E., Kunz, D., Synowitz, H., & Ansorge, S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099312957 · Cited by 90
ADAM17 mRNA expression and pathological features of hepatocellular carcinoma
Ding, X., 杨连粤, Huang, G.-W., Wang, W., & Lu, W.-Q. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i18.2735 · Cited by 83
Killock, D., & Ívetic, A. (2010) · Biochemical Journal · doi:10.1042/bj20091611 · Cited by 82
The Metzincin-Superfamily of Zinc-Peptidases
Bode, W., Grams, F., Reinemer, P., et al. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0335-0_1 · Cited by 77
ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by γ-secretase
Chalaris, A., Gewiese, J., Paliga, K., Fleig, L., Schneede, A., Krieger, K., Rose‐John, S., & Scheller, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.12.001 · Cited by 76
Self-citationImplication of APP Secretases in Notch Signaling
Hartmann, D., Tournoy, J., Säftig, P., Annaert, W. G., & Strooper, B. D. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:171 · Cited by 76
IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier
Linker, R. A., Lühder, F., Kallen, K., Lee, D.-H., Engelhardt, B., Rose‐John, S., & Gold, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.007 · Cited by 74
Self-citationErratum: Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1
Huppert, S. S., Le, A., Schroeter, E. H., Mumm, J. S., Saxena, M. T., Milner, L. A., & Kopan, R. (2000) · Nature · doi:10.1038/35046136 · Cited by 74
ADAM17 activity during human neutrophil activation and apoptosis
Walcheck, B. K., Herrera, A. H., Hill, C. S., Mattila, P. E., Whitney, A. R., & DeLeo, F. R. (2006) · European Journal of Immunology · doi:10.1002/eji.200535257 · Cited by 71
Müller‐Newen, G., Köhne, C., Keul, R., Hemmann, U., Müller‐Esterl, W., Wijdenes, J., Brakenhoff, J. P. J., Hart, M. H. L., & Heinrich, P. C. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00837.x · Cited by 70
Tanaka, M., Kishimura, M., Ozaki, S., Osakada, F., Hashimoto, H., Okubo, M., Murakami, M., & Nakao, K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7479 · Cited by 69
Apoptosis-inducing Agents Cause Rapid Shedding of Tumor Necrosis Factor Receptor 1 (TNFR1)
Madge, L. A., Sierra-Honigmann, M. R., & Pober, J. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13643 · Cited by 65
Zhang, J., Zhang, Y., Owczarek, C. M., Ward, L. D., Moritz, R. L., Simpson, R. J., Yasukawa, K., & Nicola, N. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10798 · Cited by 63
Franchimont, N., Lambert, C., Huynen, P., Ribbens, C., Relić, B., Chariot, A., Bours, V., Piette, J. G., Merville, M., & Malaise, M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20727 · Cited by 58
GP130 stimulation and the maintenance of stem cells
Rose‐John, S. (2002) · Trends in biotechnology · doi:10.1016/s0167-7799(02)02056-5 · Cited by 47
Self-citationActemra poised to launch IL-6 inhibitors
Melton, L., & Coombs, A. (2008) · Nature Biotechnology · doi:10.1038/nbt0908-957 · Cited by 37
Enzymatic control of apoptosis (1995 to Present)
Bleackley, R. C., & Heibein, J. A. (2001) · Natural Product Reports · doi:10.1039/a909080k · Cited by 32
Vahdat, A. M., Reiners, K. S., Simhadri, V. L., Eichenauer, D. A., Böll, B., Chalaris, A., Simhadri, V. R., Wiegmann, K., Krell, H. W., Rose‐John, S., et al. (2009) · Leukemia · doi:10.1038/leu.2009.230 · Cited by 28
Self-citationStoeck, A., Li, S., & Dempsey, P. J. (2010) · Journal of Cell Science · doi:10.1242/jcs.060830 · Cited by 27
Kyriakou (1997) · International Journal of Hematology · doi:10.1016/s0925-5710(97)00055-8 · Cited by 22
The function of presenilin-1 in amyloid β-peptide generation and brain development
Säftig, P., Hartmann, D., & Strooper, B. D. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050099 · Cited by 13
Cited by
Function of alternative splicing
Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., & Soreq, H. (2005) · Gene · doi:10.1016/j.gene.2004.10.022 · Cited by 1,377
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,092
Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters
Del Giudice, M., & Gangestad, S. W. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.013 · Cited by 779
Function of alternative splicing
Kelemen, O., Convertini, P., Zhang, Z., Wen, Y., Shen, M., Falaleeva, M., & Stamm, S. (2013) · Gene · doi:10.1016/j.gene.2012.07.083 · Cited by 743
Metadata
- Authors
- Chalaris, A., Garbers, C., Rabe, B., Rose-John, S., & Scheller, J.
- Venue
- European Journal of Cell Biology
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 90
- Issue
- 6-7
- Pages
- 484-494
- ISSN
- 0171-9335 (ISSN-L)
- OpenAlex
- W2022650366
- Cited by
- 289
- References
- 115
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.